Ipsen's new NJ US HQ is home from home as France becomes 'difficult'
This article was originally published in Scrip
Executive Summary
Ipsen achieved a milestone in its 10-month-old plan to double sales revenue by 2020 by focusing on specialty drug niches and expanding its global presence when the French biotechnology company opened its new US commercial headquarters on 25 April.